Cancer Vaccine
Dendritic cell vaccine elicits clinical responses in renal cancer patients
Published in Vaccine Weekly, July 9th, 2003
According to recent research from the United States, "Autologous dendritic cells transfected with total renal tumor RNA have been shown to be potent stimulators of CTLs and antitumor immunity in vitro. A Phase I trial was conducted to evaluate this strategy for feasibility, safety, and efficacy to induce tumor-specific T-cell responses in subjects with metastatic renal cell carcinoma."
"Renal tumor RNA-transfected dendritic cells were administered to 10 evaluable study patients with no evidence of dose-limiting toxicity or vaccine-related adverse...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-07-09)
More Articles from Vaccine Weekly
- Anthrax Vaccine
Interleukins-2 and -4, but not interferon-gamma, exhibit adjuvant activity - Huntington Disease
DNA vaccine prevents diabetic phenotype in Huntington disease murine model - HIV/AIDS Vaccine
DNA vaccine and microparticle boost produce potent anti-HIV immune response - Vaccine Adjuvant
Adjuvants interleukin-12 and cholera toxin enhance immunity to HIV-1 - Vaccine Development
Reverse vaccinology allows development of novel vaccines - Cancer Vaccine
Intradermal injection enhances immunogenicity and suppresses tumorigenicity - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
